INTRODUCTION: Heart failure (HF) is a serious complication of end-stage kidney disease (ESKD). However, most data come from retrospective studies that included patients on chronic hemodialysis at the time of its initiation. These patients are frequently overhydrated, which significantly influences the echocardiogram findings. The primary aim of this study was to analyze the prevalence of heart failure and its phenotypes. The secondary aims were (1) to describe the potential of N-terminal pro-brain natriuretic peptide (NTproBNP) for HF diagnosis in ESKD patients on hemodialysis, (2) to analyze the frequency of abnormal left ventricular geometry, and (3) to describe the differences between various HF phenotypes in this population. METHODS: We included all patients on chronic hemodialysis for at least 3 months from five hemodialysis units who were willing to participate, had no living kidney transplant donor, and had a life expectancy longer than 6 months at the time of inclusion. Detailed echocardiography together with hemodynamic calculations, dialysis arteriovenous fistula flow volume calculation, and basic lab analysis were performed in conditions of clinical stability. Excess of severe overhydration was excluded by clinical examination and by employing bioimpedance. RESULTS: A total of 214 patients aged 66.4 ± 14.6 years were included. HF was diagnosed in 57% of them. Among patients with HF, HF with preserved ejection fraction (HFpEF) was, by far, the most common phenotype and occurred in 35%, while HF with reduced ejection fraction (HFrEF) occurred only in 7%, HF with mildly reduced ejection fraction (HFmrEF) in 7%, and high-output HF in 9%. Patients with HFpEF differed from patients with no HF significantly in the following: they were older (62 ± 14 vs. 70 ± 14, p = 0.002) and had a higher left ventricular mass index [96(36) vs. 108(45), p = 0.015], higher left atrial index [33(12) vs. 44(16), p < 0.0001], and higher estimated central venous pressure [5(4) vs. 6(8), p = 0.004] and pulmonary artery systolic pressure [31(9) vs. 40(23), p = 0.006] but slightly lower tricuspid annular plane systolic excursion (TAPSE): 22 ± 5 vs. 24 ± 5, p = 0.04. NTproBNP had low sensitivity and specificity for diagnosing HF or HFpEF: with the use of the cutoff value of 8,296 ng/L, the sensitivity of HF diagnosis was only 52% while the specificity was 79%. However, NTproBNP levels were significantly related to echocardiographic variables, most significantly to the indexed left atrial volume (R = 0.56, p < 10-5) and to the estimated systolic pulmonary arterial pressure (R = 0.50, p < 10-5). CONCLUSIONS: HFpEF was by far the most common heart failure phenotype in patients on chronic hemodialysis and was followed by high-output HF. Patients suffering from HFpEF were older and had not only typical echocardiographic changes but also higher hydration that mirrored increased filling pressures of both ventricles than in those of patients without HF.

3rd Department of Internal Medicine 1st Faculty of Medicine General University Hospital Charles University Prague Czechia

Department of Nephrology General University Hospital 1st Faculty of Medicine Charles University Prague Czechia

Dialysis Center Cerny Most B Braun Avitum Prague Czechia

Dialysis Center Motol Fresenius Medical Care Prague Czechia

Dialysis Center Ohradni B Braun Avitum Prague Czechia

Dialysis Center Taborska B Braun Avitum Prague Czechia

Dialysis Center Uhersky Brod B Braun Avitum Uhersky Brod Czechia

Zobrazit více v PubMed

Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. (2011) 32(6):670–9. 10.1093/eurheartj/ehq426 PubMed DOI PMC

Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the heart failure association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. (2019) 40(40):3297–317. 10.1093/eurheartj/ehz641 PubMed DOI

Borlaug BA, Kass DA. Ventricular–vascular interaction in heart failure. Cardiol Clin. (2011) 29(3):447–59. 10.1016/j.ccl.2011.06.004 PubMed DOI

Malik J. Heart disease in chronic kidney disease—review of the mechanisms and the role of dialysis access. J Vasc Access. (2018) 19(1):3–11. 10.5301/jva.5000815 PubMed DOI

Moromizato T, Kohagura K, Tokuyama K, Shiohira Y, Toma S, Uehara H, et al. Predictors of survival in chronic hemodialysis patients: a 10-year longitudinal follow-up analysis. Am J Nephrol. (2021) 52(2):108–18. 10.1159/000513951 PubMed DOI

Han BA-O, Song SH, Yoo JS, Park H, Kim J, Choi E. Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis. PLoS One. (2018) 13(4):e0195202. 10.1371/journal.pone.0195202. (1932–6203). PubMed DOI PMC

Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. (2017) 28(8):2491–7. 10.1681/ASN.2016121341 PubMed DOI PMC

Modi ZJ, Lu Y, Ji N, Kapke A, Selewski DT, Dietrich X, et al. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease an analysis of the US renal data system. JAMA Cardiol. (2019) 4(4):353–62. 10.1001/jamacardio.2019.0375 PubMed DOI PMC

Inampudi C, Akintoye E, Jayanna MB, Asleh R, Briasouli A, Alvarez P, et al. Trends in in-hospital mortality, length of stay, nonroutine discharge, and cost among end-stage renal disease patients on dialysis hospitalized with heart failure (2001–2014). J Card Fail. (2019) 25(7):524–33. 10.1016/j.cardfail.2019.02.020 PubMed DOI

Malik J, Valerianova A, Pesickova SS, Hruskova Z, Bednarova V, Michalek P, et al. CZecking heart failure in patients with advanced chronic kidney disease (Czech HF-CKD): study protocol. J Vasc Access. (2022). 10.1177/11297298221099843 PubMed DOI

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. (2016) 17(4):412. 10.1093/ehjci/jew041 PubMed DOI

Kircher BJ, Himelman Rb, Fau-Schiller NB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol (1990);66(4):493–6 10.1016/0002-9149(90)90711-9 PubMed DOI

Kudlicka J, Kavan J, Tuka V, Malik J. More precise diagnosis of access stenosis: ultrasonography versus angiography. J Vasc Access. (2012) 13(3):310–4. 10.5301/jva.5000047 PubMed DOI

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. (2022) 24(1):4–131. 10.1002/ejhf.2333 PubMed DOI

Toida T, Toida R, Yamashita R, Komiya N, Uezono S, Komatsu H, et al. Grading of left ventricular diastolic dysfunction with preserved systolic function by the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations contributes to predicting cardiovascular events in hemodialysis patients. Cardiorenal Med. (2019) 9(3):190–200. 10.1159/000496064 PubMed DOI

Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. (2013) 14(7):611–44. 10.1093/ehjci/jet105 PubMed DOI

Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients—prevalence, incidence, prognosis and risk factors. Kidney Int. (1995) 47(3):884–90. 10.1038/ki.1995.132 PubMed DOI

Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int. (2004) 65(6):2380–9. 10.1111/j.1523-1755.2004.00657.x PubMed DOI

Stack AG, Bloembergen WE. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis. (2001) 38(5):992–1000. 10.1053/ajkd.2001.28588 PubMed DOI

Antlanger M, Aschauer S, Kopecky C, Hecking M, Kovarik JJ, Werzowa J, et al. Heart failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis. Kidney Blood Pres Res. (2017) 42(1):165–76. 10.1159/000473868 PubMed DOI

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. (2012) 14(8):803–69. 10.1093/eurjhf/hfs105 PubMed DOI

Savji N., Meijers W. C., Bartz T. M., Bhambhani V., Cushman M., Nayor M., et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail (2018) 6(8):701–9. 10.1016/j.jchf.2018.05.018 PubMed DOI PMC

London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol. (2001) 12(12):2759–67. 10.1681/ASN.V12122759 PubMed DOI

Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, et al. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol. (2002) 15(6):655–60. PMID: PubMed

Stevens KK, McQuarrie EP, Sands W, Hillyard DZ, Patel RK, Mark PB, Jardine AG. Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation. Int J Nephrol (2011) 2011:297070. 10.4061/2011/297070 PubMed DOI PMC

Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. (1990) 5(1):39–44. 10.1093/ndt/5.1.39 PubMed DOI

Lisi M, Cameli M, Mandoli GE, Pastore MC, Righini FM, D'Ascenzi F, et al. Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications. Heart Fail Rev. (2022) 27(5):1857–67. 10.1007/s10741-022-10214-0 PubMed DOI

Shear FE. Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives. Am J Cardiovasc Dis. (2019) 9(5):91–108. PMID: ; PMCID: PubMed PMC

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail (2016) 18(8):891–975. 10.1002/ejhf.592 PubMed DOI

Reddy YNV, Melenovsky V, Redfield MM, Nishimura RA, Borlaug BA. High-output heart failure: a 15-year experience. J Am Coll Cardiol. (2016) 68(5):473–82. 10.1016/j.jacc.2016.05.043 PubMed DOI

Choi YS, Lee IJ, An JN, Song YR, Kim SG, Lee HS, et al. High-flow arteriovenous fistula and myocardial fibrosis in hemodialysis patients with non-contrast cardiac magnetic resonance imaging. Front Cardiovasc Med. (2022) 27(9):922593. 10.3389/fcvm.2022.922593 PubMed DOI PMC

Weng SC, Chen YC, Hsu CY, Lin CS, Tarng DC, Lin SY. Impacts of heart failure and physical performance on long-term mortality in old patients with chronic kidney disease. Front Cardiovasc Med. (2021) 4(8):680098. 10.3389/fcvm.2021.680098 PubMed DOI PMC

Claus RA-O, Berliner D, Bavendiek U, Vodovar N, Lichtinghagen R, David S, et al. Soluble neprilysin, NT-proBNP, and growth differentiation factor−15 as biomarkers for heart failure in dialysis patients (SONGBIRD). Clin Res Cardiol (2020);109(8):1035–47 10.1007/s00392-020-01597-x PubMed DOI PMC

Malik J, Valerianova A, Tuka V, Trachta P, Bednarova V, Hruskova Z, et al. The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation. ESC Heart Fail. (2021) 8(3):2165–71. 10.1002/ehf2.13305 PubMed DOI PMC

Wang Y, Cao X, Yu J, Zhang Y, Li X, Chen X, et al. Association of N-terminal pro-brain natriuretic peptide with volume Status and cardiac function in hemodialysis patients. Front Cardiovasc Med. (2021) 22(8):646402. 10.3389/fcvm.2021.646402 PubMed DOI PMC

Harrison TG, Shukalek CB, Hemmelgarn BR, Zarnke KB, Ronksley PE, Iragorri N, et al. Association of NT-proBNP and BNP with future clinical outcomes in patients with ESKD: a systematic review and meta-analysis. Am J Kidney Dis. (2020) 76(2):233–47. 10.1053/j.ajkd.2019.12.017 PubMed DOI

Hwang HS, Kim JS, Kim YG, Lee YH, Lee DY, Ahn SY, et al. Circulating neprilysin level predicts the risk of cardiovascular events in hemodialysis patients. Front Cardiovasc Med. (2021) 8:684297. 10.3389/fcvm.2021.684297 PubMed DOI PMC

Right ventricular-pulmonary arterial coupling and pulmonary hypertension in hemodialysis: insights into structural cardiac changes and clinical implications

Cardiorenal Syndromes and Their Role in Water and Sodium Homeostasis